Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06800898

Orexin Gene in Anorexia Nervosa

The Methylation Level of the Orexin Gene in Anorexia Nervosa: Relationship With Eating Disorder, Depressive State, and Sleep Quality

Status
Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Istituto Auxologico Italiano · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The objectives of this study will be to determine the methylation of the promoter of the Orexin A (OX-A) and B (OX-B) genes in young women (\> 18 years) with Anorexia Nervosa (AN), compared with a control group; and to evaluate the relationship of promoter methylation of the genes for OX-A and OX-B with the severity of the eating disorder, psychiatric comorbidities (in particular, depression), and sleep quality.

Conditions

Interventions

TypeNameDescription
OTHERBlood samples and QuestionnairesBlood samples for methylation of the promoter of the OX-A and OX-B genes and questionnaires: Eating Disorder Examination Q Eating Disorder Inventory 3 Major Depression Inventory Symptom Checklist-revised ESS - Epworth Sleepiness Scale Pittsburgh Sleep Quality Index Horne \& Ostberg questionnaire

Timeline

Start date
2024-06-19
Primary completion
2026-06-30
Completion
2026-06-30
First posted
2025-01-30
Last updated
2026-03-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06800898. Inclusion in this directory is not an endorsement.